Key result
Valve-sparing surgery for bicuspid aortic valve yielded no mortality and 78.3% freedom from aortic regurgitation recurrence at 3 years, with Sievers type 2 being a strong predictor of recurrence.
Why the study?
To evaluate immediate and mid-term outcomes of valve-sparing aortic valve procedures, isolated or with concomitant ascending aorta reconstruction, in adults with bicuspid aortic valve.
Cohort (n=65)
No
Valve-sparing surgery for bicuspid aortic valve is safe and provides good mid-term freedom from recurrent regurgitation, though specific valve phenotypes (Sievers type 2 and type 1 RN) are at higher risk for recurrence.
Valve-sparing aortic surgery in BAV shows acceptable early results in small retrospective series; leaves open need for prospective durability data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Karadzha et al. (2021) conducted a cohort in Bicuspid aortic valve with aortic regurgitation and/or ascending aortic aneurysm (n=65). Valve-sparing surgery was evaluated on Freedom from aortic regurgitation recurrence at 3 years. Valve-sparing surgery for bicuspid aortic valve yielded no mortality and 78.3% freedom from aortic regurgitation recurrence at 3 years, with Sievers type 2 being a strong predictor of recurrence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: